Results for tag: "Ranirestat"

Ranirestat is a cardiovascular drug used to treat dyslipidemia, a condition characterized by an abnormal amount of lipids in the blood. It is a selective inhibitor of acyl-CoA:cholesterol acyltransferase (ACAT) and works by reducing the production of cholesterol in the liver. Ranirestat is approved for use in adults with primary hypercholesterolemia, a condition in which the body produces too much cholesterol. It is also used to reduce the risk of cardiovascular events in adults with established cardiovascular disease. Ranirestat is available in both oral and injectable forms. The oral form is taken once daily, while the injectable form is administered once every two weeks. Common side effects of Ranirestat include headache, nausea, and muscle pain. The Ranirestat market is highly competitive, with several major pharmaceutical companies offering the drug. These include Merck & Co., Pfizer, and AstraZeneca. Other companies in the market include Sanofi, Novartis, and GlaxoSmithKline. Show Less Read more